Literature DB >> 3260526

Bone marrow histopathologic patterns and immunologic phenotype in B-cell chronic lymphocytic leukaemia.

A Orfao1, M Gonzalez, J San Miguel, A Rios, M D Caballero, M Sanz, M J Calmuntia, P Galindo, A Lopez Borrasca.   

Abstract

The present work analyzes the clinicobiological and immunological characteristics - the latter hitherto unexplored - of the different bone marrow histopathological patterns of the B-cell chronic lymphocytic leukaemia (B-CLL). In addition, we studied whether any or some of these parameters were able to predict the probability of a particular pattern of bone marrow involvement appearing. Of the 100 B-CLL cases studied 41 had a diffuse pattern and 59 were non-diffuse - interstitial 27, nodular 11 and mixed 21 -. Neither clinical nor immunological differences were observed among the distinct non-diffuse patterns. The patients in the diffuse group displayed an increased incidence of mu+ isotype and a higher proportion of HLA-DR and HAN-PC 1 positive cells while, conversely, reactivity with the FMC 8 McAb was lower. In addition, patients with a diffuse pattern of BM involvement displayed features of a more extensive disease: a higher incidence of adenopathies (p less than 0.05), hepatomegaly (p less than 0.01), splenomegaly (p less than 0.01), anaemia (p less than 0.01) and thrombopenia (p less than 0.01) as well as higher levels of peripheral blood lymphocytosis (p less than 0.05) and a higher percentage of BM lymphocytic infiltration (p less than 0.001). Multiple regression analysis showed that thrombopenia and splenomegaly were the two most important features in predicting the probability of a diffuse pattern.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3260526     DOI: 10.1007/bf00320630

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  22 in total

1.  Surface phenotype and clinical stages in B-cell chronic lymphocytic leukaemia.

Authors:  A Orfao; M Gonzalez; J F San Miguel; M J Moro; J Fernandez-Calvo; M Carnero; P Galindo; A Lopez Borrasca
Journal:  Haematologica       Date:  1987 Jan-Feb       Impact factor: 9.941

2.  [A new monoclonal antibody produced against a human leukemia which recognizes class II HLA antigens].

Authors:  F Ruiz-Cabello; M González; M A López; A Cabrera; J San Miguel; F Garrido
Journal:  Sangre (Barc)       Date:  1985

3.  Bone marrow and peripheral blood lymphocytosis in the prognosis of chronic lymphocytic leukemia.

Authors:  J L Gray; A Jacobs; M Block
Journal:  Cancer       Date:  1974-04       Impact factor: 6.860

4.  Maturation of human B lymphocytes--studies with a panel of monoclonal antibodies against membrane antigens.

Authors:  H Zola; P J McNamara; H A Moore; I J Smart; D A Brooks; I G Beckman; J Bradley
Journal:  Clin Exp Immunol       Date:  1983-06       Impact factor: 4.330

5.  Bone-marrow patterns and clinical staging in chronic lymphocytic leukaemia.

Authors:  L Hernandez-Nieto; E Montserrat-Costa; J Muncunill; C Rozman
Journal:  Lancet       Date:  1977-06-11       Impact factor: 79.321

6.  Phenotypes in chronic B-lymphocytic leukemia probed by monoclonal antibodies and immunoglobulin secretion studies: identification of stages of maturation arrest and the relation to clinical findings.

Authors:  J Gordon; H Mellstedt; P Aman; P Biberfeld; M Björkholm; G Klein
Journal:  Blood       Date:  1983-10       Impact factor: 22.113

7.  Bone-marrow patterns and clinical staging in chronic lymphocytic leukaemia.

Authors:  A Carbone; A Santoro; S Pilotti; F Rilke
Journal:  Lancet       Date:  1978-03-18       Impact factor: 79.321

8.  Prognostic significance of bone-marrow patterns in chronic lymphocytic leukaemia.

Authors:  C Rozman; L Hernandez-Nieto; E Montserrat; R Brugues
Journal:  Br J Haematol       Date:  1981-04       Impact factor: 6.998

9.  Bone marrow biopsy and clinical staging in chronic lymphocytic leukemia.

Authors:  M D Lipshutz; R Mir; K R Rai; A Sawitsky
Journal:  Cancer       Date:  1980-09-15       Impact factor: 6.860

10.  Bone marrow histologic pattern--the best single prognostic parameter in chronic lymphocytic leukemia: a multivariate survival analysis of 329 cases.

Authors:  C Rozman; E Montserrat; J M Rodríguez-Fernández; R Ayats; T Vallespí; R Parody; A Ríos; D Prados; M Morey; F Gomis
Journal:  Blood       Date:  1984-09       Impact factor: 22.113

View more
  1 in total

1.  Reticulin fibre content of bone marrow infiltrates of malignant non-Hodgkin's lymphomas (B-cell type, low malignancy)--a morphometric evaluation before and after therapy.

Authors:  J Thiele; J Langohr; M Skorupka; R Fischer
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.